Picture of Abliva AB logo

ABLI — Abliva AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Neurovive and Lund university receive grant for liver cancer research

Oct 18 (Reuters) - NEUROVIVE PHARMACEUTICAL AB  NVP.ST  
    * NEUROVIVE AND LUND UNIVERSITY COLLABORATION RECEIVES GRANT 
FOR LIVER CANCER RESEARCH 
    * GRANTED 2.5 MSEK FROM SWEDISH FOUNDATION FOR STRATEGIC 
RESEARCH 
    * NEUROVIVE AND RAMIN MASSOUMI HAVE BEEN GRANTED 2.5 MSEK 
TO STUDY ROLE OF CYCLOPHILINS IN LIVER CANCER 
 
Source text for Eikon:  ID:nWkrbRB04Q  
Further company coverage:  NVP.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Abliva AB

See all news